Zobrazeno 1 - 10
of 77
pro vyhledávání: '"MA Mychaskiw"'
Publikováno v:
Journal of Health Economics and Outcomes Research
Background: Pulmonary arterial hypertension (PAH) is a disease characterized by dyspnea, fatigue, chest pain and syncope. As there is no known cure for PAH, the goal of treatment is to control symptoms and slow disease progression. Sildenafil, a phos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26c0632a5172060f5829afa722aa1a6a
https://pubmed.ncbi.nlm.nih.gov/34430662
https://pubmed.ncbi.nlm.nih.gov/34430662
Autor:
MA Mychaskiw, Nicholas J. Vendetti, Joseph Thomas, Jack Mardekian, Daniel I. Levy, Neeraj N Iyer
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Neeraj N Iyer,1 Nicholas J Vendetti,2 Daniel I Levy,3 Jack Mardekian,4 Marko A Mychaskiw,2 Joseph Thomas III1 1Regenstrief Center for Healthcare Engineering and Center for Health Outcomes Research and Policy, College of Pharmacy, Purdue University, W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::548760aff00e3c9ea3ad75ff9871143f
http://europepmc.org/articles/PMC6216970
http://europepmc.org/articles/PMC6216970
Publikováno v:
Clinical Therapeutics. 37:1055-1063
Purpose Pulmonary arterial hypertension (PAH) can be a complication in patients with connective tissue disease (CTD). Although the phosphodiesterase-5 inhibitor sildenafil shows evidence of efficacy and tolerability among patients with PAH associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df063113a7f8fd5c1869b853989a019b
https://doi.org/10.1016/j.clinthera.2015.02.025
https://doi.org/10.1016/j.clinthera.2015.02.025
Publikováno v:
Clinical Rheumatology
Pulmonary arterial hypertension (PAH) is a progressive and life-threatening disease. Understanding of PAH prevalence remains limited, but PAH has been reported as a frequent complication in connective tissue diseases. This study estimated prevalence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14ef81822c727ecbe324c0be7678f8c7
https://doi.org/10.1007/s10067-013-2307-2
https://doi.org/10.1007/s10067-013-2307-2
Publikováno v:
The European Journal of Health Economics
The objective of the present study was to describe a new model of the cost-effectiveness of treatment of generalized anxiety disorder (GAD) and its application to a comparison of pregabalin versus venlafaxine extended-release (XR) from a Spanish heal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82424b1b13403299ccbe28d153a3d207
http://europepmc.org/articles/PMC2816249
http://europepmc.org/articles/PMC2816249
Publikováno v:
Eye. 23:1668-1674
To compare responses in two patient populations with a questionnaire developed to identify those prescribed ocular hypotensive medication whose adherence may need improvement and who may be ready to change.The content/face validity of a 62-item, self
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ceb607593940d2dc89a4ab69257715d
https://doi.org/10.1038/eye.2008.337
https://doi.org/10.1038/eye.2008.337
Publikováno v:
Ophthalmology. 114:648-652
Purpose Persistence with ocular hypotensive medication is important as a long-term outcome, and rates of persistence typically are low. This study assessed restart rates for 3 prostaglandin analogs by determining the percentage of patients who discon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc1b748650a4b6f362ef26e12516a387
https://doi.org/10.1016/j.ophtha.2006.09.025
https://doi.org/10.1016/j.ophtha.2006.09.025
Publikováno v:
Journal of Pulmonary & Respiratory Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::615f10990cdeb469a67169790c41e48e
https://doi.org/10.4172/2161-105x.s4-002
https://doi.org/10.4172/2161-105x.s4-002
Publikováno v:
BMC Pulmonary Medicine, Vol 12, Iss 1, p 54 (2012)
BMC Pulmonary Medicine
BMC Pulmonary Medicine
Background The 6-minute walk test evaluates the effect of pharmacologic intervention in adults with pulmonary arterial hypertension (PAH) but, for reasons of compliance or reliability, may not be appropriate for children at all ages. Thus, peak oxyge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5aa0d19e229cd4cef3115ea9fac32a7
https://doi.org/10.1186/1471-2466-12-54
https://doi.org/10.1186/1471-2466-12-54
Autor:
MA Mychaskiw, Kafi N. Sanders, Jose Alvir, Kristin M. Richards, Andrew Goddard, Dana Stafkey-Mailey, Karen L. Rascati, Carol A. Ott
Publikováno v:
Psychiatric services (Washington, D.C.). 62(9)
A retrospective study using Medicaid claims identified patients with bipolar disorder for whom oral second-generation antipsychotics were prescribed and compared rates of adherence, persistence of use, and costs across five groups of patients taking
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a44ba42700d461ea7f3b8cf138814969
https://pubmed.ncbi.nlm.nih.gov/21885581
https://pubmed.ncbi.nlm.nih.gov/21885581